273 related articles for article (PubMed ID: 31310624)
1. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
Chen KY; Chen CC; Chang YC; Chang MC
PLoS One; 2019; 14(7):e0219317. PubMed ID: 31310624
[TBL] [Abstract][Full Text] [Related]
2. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
4. Conjugated Physiological Resveratrol Metabolites Induce Senescence in Breast Cancer Cells: Role of p53/p21 and p16/Rb Pathways, and ABC Transporters.
Giménez-Bastida JA; Ávila-Gálvez MÁ; Espín JC; González-Sarrías A
Mol Nutr Food Res; 2019 Nov; 63(22):e1900629. PubMed ID: 31441212
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol promotes oxidative stress to drive DLC1 mediated cellular senescence in cancer cells.
Ji S; Zheng Z; Liu S; Ren G; Gao J; Zhang Y; Li G
Exp Cell Res; 2018 Sep; 370(2):292-302. PubMed ID: 29964052
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
8. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
10. Silencing Snail suppresses tumor cell proliferation and invasion by reversing epithelial-to-mesenchymal transition and arresting G2/M phase in non-small cell lung cancer.
Yang X; Han M; Han H; Wang B; Li S; Zhang Z; Zhao W
Int J Oncol; 2017 Apr; 50(4):1251-1260. PubMed ID: 28259904
[TBL] [Abstract][Full Text] [Related]
11. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
[TBL] [Abstract][Full Text] [Related]
12. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.
Colin DJ; Limagne E; Ragot K; Lizard G; Ghiringhelli F; Solary É; Chauffert B; Latruffe N; Delmas D
Cell Death Dis; 2014 Nov; 5(11):e1533. PubMed ID: 25412311
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells.
Li B; Hou D; Guo H; Zhou H; Zhang S; Xu X; Liu Q; Zhang X; Zou Y; Gong Y; Shao C
Sci Rep; 2017 Mar; 7(1):208. PubMed ID: 28303009
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC
Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163
[TBL] [Abstract][Full Text] [Related]
16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
17. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.
Luo H; Yang A; Schulte BA; Wargovich MJ; Wang GY
PLoS One; 2013; 8(3):e60065. PubMed ID: 23533664
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.
Bao L; Diao H; Dong N; Su X; Wang B; Mo Q; Yu H; Wang X; Chen C
Cell Biol Toxicol; 2016 Dec; 32(6):469-482. PubMed ID: 27423454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
